{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:05:28Z","timestamp":1774645528843,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.amjmed.2009.12.018","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T04:44:40Z","timestamp":1271393080000},"page":"469.e1-469.e7","source":"Crossref","is-referenced-by-count":20,"title":["Effect of Raloxifene on All-cause Mortality"],"prefix":"10.1016","volume":"123","author":[{"given":"Deborah","family":"Grady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Cauley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2009.12.018_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.amjmed.2009.12.018_bib2","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jcem.87.8.8750","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.amjmed.2009.12.018_bib3","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjmed.2009.12.018_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.amjmed.2009.12.018_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjmed.2009.12.018_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/djn153","article-title":"Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk","volume":"100","author":"Grady","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.amjmed.2009.12.018_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.amjmed.2009.12.018_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/STROKEAHA.108.518621","article-title":"Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease","volume":"40","author":"Mosca","year":"2009","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.amjmed.2009.12.018_bib9","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.amjmed.2009.12.018_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjmed.2009.12.018_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ahj.2003.12.019","article-title":"Cardiovascular effects of raloxifene: the arterial and venous systems","volume":"147","author":"Blumenthal","year":"2004","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.amjmed.2009.12.018_bib12","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/01.CCM.0000227173.13497.56","article-title":"WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock","volume":"34","author":"Cristofaro","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjmed.2009.12.018_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","article-title":"Vertebral fractures and mortality in older women: a prospective study","volume":"159","author":"Kado","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.12.018_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.amjmed.2009.01.033","article-title":"Raloxifene and risk for stroke based on the Framingham stroke risk score","volume":"122","author":"Barrett-Connor","year":"2009","journal-title":"Am J Med"}],"updated-by":[{"DOI":"10.1016\/j.amjmed.2010.07.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000}}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:25:22Z","timestamp":1544549122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934310000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0002934310000677"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.12.018","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}